Skip to main content
. 2022 Feb 23;10:822785. doi: 10.3389/fchem.2022.822785

FIGURE 4.

FIGURE 4

Crystal structures of SARS-CoV-2 PLpro in complex with covalent inhibitors. (A) Superposition of SARS-CoV-2 PLpro (light blue; PDB ID: 6WZU) with VIR250/PLpro (green; PDB ID: 6WUU) and VIR251/PLpro (cyan; PDB ID: 6WX4) complexes. The blocking loop 2 is indicated. (B) Surface presentation of VIR250 binding pocket. PLpro is shown as gray surface, while VIR250 is shown as sticks. The catalytic cysteine of PLpro forms a covalent bond with VIR250. The P2-P4 positions are labeled. (C) Surface presentation of VIR251 binding pocket. PLpro is shown as gray surface, while VIR251 is shown as sticks. The catalytic cysteine of PLpro forms a covalent bond with VIR251. The P2-P4 positions are labeled.